WuXi Biologics (Cayman) Inc
OTC:WXXWY
Relative Value
The Relative Value of one
WXXWY
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 8.75 USD,
WuXi Biologics (Cayman) Inc
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
WXXWY Competitors Multiples
WuXi Biologics (Cayman) Inc Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
|
WuXi Biologics (Cayman) Inc
OTC:WXXWY
|
140.6B USD | 6.1 | 29.3 | 20.3 | 20.3 | |
| US |
P
|
PerkinElmer Inc
LSE:0KHE
|
949.8B USD | 332.5 | 3 937.7 | 1 128.4 | 2 172.8 | |
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
174.7B USD | 3.9 | 26.1 | 18.4 | 24.7 | |
| US |
|
Danaher Corp
NYSE:DHR
|
132.4B USD | 5.4 | 36.6 | 18.7 | 27.2 | |
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
82.3T KRW | 18.1 | 46.1 | 30.1 | 39.4 | |
| CH |
|
Lonza Group AG
SIX:LONN
|
33.2B CHF | 5.1 | 35 | 26.1 | 26.1 | |
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
262.9B CNY | 5.9 | 17.4 | 17.4 | 17.4 | |
| US |
|
Agilent Technologies Inc
NYSE:A
|
31.5B USD | 4.5 | 24.5 | 19.2 | 23 | |
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
27.9B USD | 1.7 | 20.6 | 11.6 | 17.4 | |
| US |
|
Waters Corp
NYSE:WAT
|
28.1B USD | 8.9 | 43.7 | 28.2 | 35.5 | |
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
23.9B USD | 5.9 | 27.5 | 20.5 | 22.8 |